Clinical Trial Update: The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing LINX device to double-dose PPI therapy for GERD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• LINX
• Proton Pump Inhibitor therapy (double-dose) (proton pump inhibitor)

Snippet

Sponsor: Torax Medical Incorporated | Conditions: GERD Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-12-12